Japan Intellectual Property Rights: SUBCUTANEOUS ADMINISTRATION OF NANOPARTICLES COMPRISING MTOR INHIBITOR AND ALBUMIN FOR TREATMENT OF DISEASES

Japan, Nov. 6 -- ABRAXIS BIOSCIENCE LLC has got intellectual property rights for 'SUBCUTANEOUS ADMINISTRATION OF NANOPARTICLES COMPRISING MTOR INHIBITOR AND ALBUMIN FOR TREATMENT OF DISEASES.' Other related details are as follows:

Application Number: JP,2025-060500

Category (FI): A61P43/00,105,A61P43/00,111,A61K9/51,A61M5/178,A61K47/42,A61K45/00,A61M5/20,A61M5/24,530,A61J1/05,351@A,A61P35/00,A61K47/36,A61K47/26,A61K31/436

Stage: Grant (IP right granted following substantive examination.)

Filing Date: April 1, 2025

Publication Date: Aug. 13, 2025

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication.